Shortly after Milena Adamian joined the San Francisco office of Easton Capital in 2007, she got involved in two local angel groups, Life Science Angels and Health Tech Capital. Adamian, who is a cardiologist by training, was drawn to the opportunity to support fledgling entrepreneurs—some of whom were developing new drugs and devices that she … Continue reading “New York Angels Step Up to Fund Local Biotech and Medtech Startups”
Category: National
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug
[Update: 12:03 pm ET, with pricing info] Vertex’s big day has arrived. The Cambridge, MA-based biotech company has gotten clearance from the FDA to start marketing telaprevir (Incivek) as a new treatment for patients in the U.S. with hepatitis C. The new drug, a protease inhibitor designed to fight the liver-damaging virus, is now approved … Continue reading “Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug”
BzzAgent Bought by Tesco’s Dunnhumby, Brings Social Marketing Expertise to Retail Giant
Boston social-marketing company BzzAgent said today it is being acquired by U.K.-based consumer analytics firm Dunnhumby, a subsidiary of retail giant Tesco. Terms were not disclosed, but various media reports put the acquisition price at $60 million, contingent on BzzAgent hitting certain milestones. BzzAgent started in 2001 and has amassed a network of 800,000 consumer … Continue reading “BzzAgent Bought by Tesco’s Dunnhumby, Brings Social Marketing Expertise to Retail Giant”
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy
[Correction: 10:22 am 5/24/11] Bluebird Bio is one of those fortunate companies that can say the top peer-reviewed journals in biomedical research—Science and Nature—have run articles featuring its two lead drug candidates while they are still at the earliest phase of development. CEO Nick Leschly doesn’t want to sound ungrateful—the buzz doesn’t hurt—but he seems … Continue reading “Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy”
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting
Word on the street in Seattle last week was that Big Pharma was sniffing around quite a bit at the American Society of Gene & Cell Therapy annual meeting being held downtown. There was a lot more optimism at this confab than in years past, and Richmond, CA-based Sangamo Biosciences was one of the companies … Continue reading “Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting”
Active Network Teed Up for IPO This Week, InterDigital Opens Local Lab, Aptera Ready to Move Production Out of California, & More San Diego BizTech News
The big news this week, if it happens, will be the Active Network’s IPO. But we’ve also rounded up all the other important developments from San Diego’s tech community, and our briefing begins now. —The San Diego-based Active Network could have a market valuation that is close to $1 billion if its IPO takes place … Continue reading “Active Network Teed Up for IPO This Week, InterDigital Opens Local Lab, Aptera Ready to Move Production Out of California, & More San Diego BizTech News”
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired
Most biotech entrepreneurs I’ve met have a dream that ends one of two ways. They will either take their company public, or sell their startup to a giant drugmaker. Those are the paths to making money, making venture investors happy, and getting the resources needed to take a new drug all the way to the … Continue reading “How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired”
Kareem Abdul-Jabbar Gives Lift to Skyhook Wireless By Following CEO Ted Morgan on Twitter
If you’re a loyal reader of Xconomy, and have followed stories such as VC Varsity, you know we aren’t above finding a sports angle to our coverage of the innovation community. Skyhook Wireless is no exception. The company was founded by Ted Morgan and Michael Shean and named in part because of their love of … Continue reading “Kareem Abdul-Jabbar Gives Lift to Skyhook Wireless By Following CEO Ted Morgan on Twitter”
Separating Hype from Reality in Alternative Fuels: the Photo Gallery
Even though the sun was finally out in Seattle, dozens of folks from the worlds of cleantech, life sciences and high tech got together to share thoughts and network at Xconomy’s latest event, “Separating Hype from Reality in Alternative Fuels.” Our panelists and presenters dove into the past and future of biofuels, the need for … Continue reading “Separating Hype from Reality in Alternative Fuels: the Photo Gallery”
Electric Cars Won’t Take Over, Biofuels 3.0 Must Fix the Bugs, & Microorganisms as Problem-Solvers: Big Ideas from Cleantech Leaders
We had a great time at our latest Xconomy Seattle event, “Separating Hype from Reality in Alternative Fuels,” held last night at the new Institute for Systems Biology headquarters in Seattle’s South Lake Union neighborhood. The presenters sketched some meaty ideas about the drive to develop oil alternatives, challenged a bit of conventional thinking, and … Continue reading “Electric Cars Won’t Take Over, Biofuels 3.0 Must Fix the Bugs, & Microorganisms as Problem-Solvers: Big Ideas from Cleantech Leaders”
Adapx, a Digital-Pen Company With Serious Military Chops, Adds $5M to Modernize Note-Taking
Seattle-based Adapx, which aims to speed up workflows by making it easier to mark up digital documents, has raised a new financing round of $5 million and says it has grown to about 800 customers. Adapx (pronounced “adapts”) said the money would be used to expand its Capturx software line for mainstream business uses and … Continue reading “Adapx, a Digital-Pen Company With Serious Military Chops, Adds $5M to Modernize Note-Taking”
Get Your Hack On: Detroit Geeks Make Finals of National Hacker Contest in New York
A few weeks ago, I asked tech entrepreneur Dug Song, co-founder of Arbor Networks, what Michigan needs in order to build its own Silicon Valley. He did not hesitate. “Hackers,” Song replied. No, not the kind that breaks into the Pentagon or Federal Reserve and initiates Doomsday. Rather, tech geeks who fiddle with stuff in … Continue reading “Get Your Hack On: Detroit Geeks Make Finals of National Hacker Contest in New York”
Garageband on the iPad Makes Amateur Musicians into Artists
Can you be a composer without being a musician? Thanks to the latest generation of music authoring software, the answer is yes. Take me, for example. I played the trombone in high school, and I can still read music (bass clef anyway), but I would be very hard pressed to strum a guitar chord, keep … Continue reading “Garageband on the iPad Makes Amateur Musicians into Artists”
Mobile Startup Session M Emerges with $6.5M from Highland, KPCB
Interesting news in the mobile scene today. Session M, a new Boston-area startup, announced it has raised $6.5 million in Series A financing from Highland Capital Partners, Kleiner Perkins Caufield & Byers (iFund), and mobile industry leaders. Bob Davis from Highland and Matt Murphy from KPCB serve on the company’s board. As is often the … Continue reading “Mobile Startup Session M Emerges with $6.5M from Highland, KPCB”
Multiple Pathways to the Exit: Canaan’s Bloch on Advanced BioHealing Buyout
The $750 million sale of Advanced BioHealing to the Irish drug giant Shire Pharmaceuticals, announced on Tuesday, has been hailed as a rare win for regenerative medicine, with an extraordinary 15x return for Canaan Partners, the venture firm that helped to found the company just five years ago. But as I noted in a 2009 … Continue reading “Multiple Pathways to the Exit: Canaan’s Bloch on Advanced BioHealing Buyout”
Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare
In October, New York-based investment firm Miller Tabak launched the Health Care Transformation Fund (MTHFX), which invests in managed care, biotech, pharmaceuticals, and medtech companies. Its top holdings include New York area pharma giants Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) and Merck (NYSE: [[ticker:MRK]]), as well as Boston-based biotech Momenta Pharmaceuticals (NASDAQ: [[ticker:MNTA]]). The fund’s manager, Les Funtleyder, … Continue reading “Miller Tabak Fund Manager Says Investors Are Ignoring the Upsides in Healthcare”
DataXu, Recent Investment in Tow, Helps Brands Follow Consumers as More Ads Go Digital
Here’s a quick snapshot of a local tech company that lots of people talk about, but not usually in much depth. Probably because it focuses on helping online advertisers understand consumers, but it’s not for consumers. Boston-based DataXu has been growing fast over the past year, and now has offices in Boston, New York, San … Continue reading “DataXu, Recent Investment in Tow, Helps Brands Follow Consumers as More Ads Go Digital”
PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News
We saw news on both the drugs and medical devices sides of the life sciences industry in New England this week. —PerkinElmer (NYSE: [[ticker:PKI]]), a Waltham, MA-based provider of life sciences tools, said it acquired Labtronics, an Ontario, Canada-based provider of electronic laboratory notebook products. Deal terms weren’t disclosed. —Two-year-old Foundation Medicine of Boston revealed it … Continue reading “PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News”
Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News
Our roundup of San Diego’s biotech news is short, but we had some important developments over the past week. Your update begins now. — Westport, CT-based Advanced BioHealing, which makes Dermagraft bio-engineered skin patches in San Diego, agreed to a $750 million buyout offer from Shire (NASDAQ: [[ticker:SHPGY]]), the Irish pharmaceutical drug maker. The deal … Continue reading “Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News”
See You Tonight at “Separating Hype from Reality in Alternative Fuels”
Gas is $4 a gallon, consumers are steaming, the oil companies keep getting tax breaks, and alternative fuels are still a long way from reaching the consumer masses. What’s going on here? There’s a lot of meaty material to discuss as I’m getting ready for tonight’s Xconomy event, titled “Separating Hype from Reality in Alternative … Continue reading “See You Tonight at “Separating Hype from Reality in Alternative Fuels””
Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus
San Francisco-based Jennerex Biotherapeutics isn’t ready to show results from its tumor-fighting virus at the meeting that attracts all the big boys and girls in the cancer drug business, but today it is unveiling some provocative results that suggest it may help liver cancer patients live longer. Jennerex’s data is still preliminary, and comes from … Continue reading “Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus”
Ostial Solutions, Targeted Catheter System Maker, Raises $137K
Ostial Solutions has raised $137,530 from the sale of equity, according to SEC documents. The medical device startup, based in Kalamazoo, MI, is seeking about $350,000, the filing says. Founded in 2003, Ostial’s guided catheter technology helps surgeons to precisely position a stent, a device that props open clogged arteries, in patients suffering blockages occurring … Continue reading “Ostial Solutions, Targeted Catheter System Maker, Raises $137K”
Pacira Raises Wall Street Expectations of a New Blockbuster Painkiller
The last time Xconomy checked in with Pacira Pharmaceuticals (NASDAQ: [[ticker:PCRX]]), in early 2009, the company was laying off a third of its workforce in the wake of a disappointing clinical trial of Exparel, a treatment for post-surgical pain. Pacira was capital-constrained because the market for life-sciences IPOs was all but dead. And the future … Continue reading “Pacira Raises Wall Street Expectations of a New Blockbuster Painkiller”
Boston Venture Firms on the Move: A Roundup of Who’s Heading West (to CA), and Who’s Heading East (to Cambridge)
Updated, see below—The January 2009 announcement by Y Combinator that it was leaving the Boston area and moving full-time to Silicon Valley gave a real jolt to the local innovation community. Then, only a few months later, Greylock Partners dropped a similar bombshell. The storied venture firm, arguably in the elite of the elite alongside … Continue reading “Boston Venture Firms on the Move: A Roundup of Who’s Heading West (to CA), and Who’s Heading East (to Cambridge)”
TechStars Boston Alum Sensobi Joins Forces With GroupMe To Better Organize Mobile Social Network
Mobile app developer Sensobi reaped the benefits of the tight-knit New York tech startup community earlier this month, you could say. CEO and founder Ajay Kulkarni calls it “a fortuitous introduction that turned into something bigger.” That would be Sensobi’s acquisition by GroupMe. Sensobi, which I profiled last January, offers a $10 BlackBerry app that … Continue reading “TechStars Boston Alum Sensobi Joins Forces With GroupMe To Better Organize Mobile Social Network”
Resolve Maps Out New Biotech Model, SeaGen Expands, Schadt Heads East, & More in Seattle-Area Life Sciences News
Local biotech people and companies were moving onward and upward this week. —Eric Schadt, the shorts-wearing, motorcycle-riding genomics brainiac, the guy who made his name at Seattle’s Rosetta Inpharmatics, is moving to the Big Apple to run a big new genomics institute at Mt. Sinai School of Medicine. Schadt, a co-founder of Seattle-based Sage Bionetworks, … Continue reading “Resolve Maps Out New Biotech Model, SeaGen Expands, Schadt Heads East, & More in Seattle-Area Life Sciences News”
Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine
It’s the season for playoff-level intensity for a bunch of Big Pharma and biotech companies. They’re all psyched up, over the next two weeks, to show clinical trial results for their drugs at the annual extravaganza for cancer doctors, put on by the American Society of Clinical Oncology (ASCO). Win over those influential doctors, and … Continue reading “Genentech Gears Up for ASCO, Pushing Data on Personalized Cancer Medicine”
Eventbrite Goes On a $50 Million E Ticket Ride
Nobody under 40 would remember this, but until 1982, Disney sold tickets in its theme parks by the ride rather than charging admission by the day. The newest, best rides required an E ticket, which was the most expensive denomination, hence the popular phrase “E Ticket Ride,” referring to “an unusually interesting, thrilling, or expensive … Continue reading “Eventbrite Goes On a $50 Million E Ticket Ride”
Take That, Gmail: San Francisco Goes With Microsoft For Cloud-Based Email Upgrade
Microsoft has scored a bit of a coup in rival Google’s backyard: The Redmond, WA-based software giant has landed a contract to provide cloud-based email for San Francisco’s city and county government, winning out against options from Google (NASDAQ: [[ticker:GOOG]]) and Lotus. San Francisco will pay Microsoft (NASDAQ: [[ticker:MSFT]]) about $1.2 million per year for … Continue reading “Take That, Gmail: San Francisco Goes With Microsoft For Cloud-Based Email Upgrade”
Medtronic’s Hawkins and BSX’s Elliott Exit Stage Right As Medical Device Industry Shifts
It’s pretty tough to be a CEO at a major medical device company these days. Just ask Bill Hawkins, who was reportedly pushed out at Medtronic and Ray Elliott, who abruptly left Boston Scientific. I’m not sure if the two men ever knew each other but their departures have a weird type of symmetry. Both … Continue reading “Medtronic’s Hawkins and BSX’s Elliott Exit Stage Right As Medical Device Industry Shifts”
Boeing’s NW Biofuel Strategy, Kleiner Perkins’ Natural Gas Startup & More on Deck for Tomorrow’s Alternative Fuels Event
Gas is selling for more than $4 a gallon, and consumers are hopping mad. Even though we’ve all seen this movie before, nobody has yet made a serious impact with alternatives that power motor vehicles with something other than fossil fuels. Finding various clean, renewable, and cost-competitive sources of energy is one of the big … Continue reading “Boeing’s NW Biofuel Strategy, Kleiner Perkins’ Natural Gas Startup & More on Deck for Tomorrow’s Alternative Fuels Event”
Wherefore Art Thou Angels? Boston Startup Scene Gears Up for Angel Bootcamp on June 14 (and Wants a Little More Froth)
Yes, I’m well aware that “wherefore” means “for what reason.” In this case, the reasons for being an active angel investor in Boston have to do with being part of a bigger and collaborative ecosystem, giving back to the startup community, and helping create the future of technology. It’s exciting stuff—especially in this day and … Continue reading “Wherefore Art Thou Angels? Boston Startup Scene Gears Up for Angel Bootcamp on June 14 (and Wants a Little More Froth)”
SDG&E, Soitec Add 2 Local Solar Sites
San Diego Gas & Electric has added two more 25-year contracts with French-based Soitec, which will supply a total of 125 megawatts from solar energy sites using Soitec’s Concentrix CPV (Concentrating Photo-Voltaic solar panel modules. In a statement today, the two companies say Soitec Solar Development will manufacture the modules in a new factory to … Continue reading “SDG&E, Soitec Add 2 Local Solar Sites”
Clearwire Hands Network Management to Sprint Partner Ericsson, Continuing Rapid Makeover
Wireless network provider Clearwire (NASDAQ: [[ticker:CLWR]]) continues taking significant steps to remake itself. Today, the Kirkland, WA-based company announced it is handing over day-to-day management of its fourth-generation (4G) network to Ericsson (NASDAQ: [[ticker:ERIC]]). The move means that about 700 Clearwire employees will work for Ericsson, “in locations around the United States before mid-year 2011,” … Continue reading “Clearwire Hands Network Management to Sprint Partner Ericsson, Continuing Rapid Makeover”
SiGe Opts for $275M Acquisition Instead of IPO
Andover, MA-based SiGe Semiconductor, which first revealed its plans to go public last July, is instead set to be acquired by another Bay State semiconductor technology company, Skyworks (NASDAQ: [[ticker:SWKS]]). Woburn, MA-based Skyworks, whose analog and mixed signal semiconductors have applications in the military, medical, broadband, mobile, industrial, automotive, and energy management spaces, will pay as … Continue reading “SiGe Opts for $275M Acquisition Instead of IPO”
Innovation as King Is Dead. The Day of the Innovator Has Arrived
[This post was co-authored by Joseph Steig of VentureWell—Eds.] The United States needs new, bold science innovation to address the challenges facing people and the planet—and to create jobs and a strong economy. Yet what is glamorous in popular business culture is not science innovation, but rather bold pitches, business innovations, fast and big exits. … Continue reading “Innovation as King Is Dead. The Day of the Innovator Has Arrived”
Finding a Solution To Our Biotech Malaise Together
We have many problems in biotechnology but I think Seattle is well positioned to overcome those barriers. Bear with me as I work to one possible approach. I think there are two problems weighing on the biotechnology industry producing the current melancholy – lack of sustainable employment over a career and the inability to change … Continue reading “Finding a Solution To Our Biotech Malaise Together”
Should Biology Go Open Source? Join the Debate June 16 With Phil Sharp and Stephen Friend
Biology has long been based on a model in which scientists think up a dynamite experiment, gather data, keep it all close to the vest, and publish the (hoped-for) blockbuster results in a top peer-reviewed journal. Like many biologists, MIT’s Phil Sharp made his name following this time-honored method for discovering and disseminating knowledge. Now … Continue reading “Should Biology Go Open Source? Join the Debate June 16 With Phil Sharp and Stephen Friend”
Amyris Sees Reward in Putting One Foot in Front of the Other in Biofuels
The renewable fuels business has been long on talk and short on action for a few years now. That helps explain how Emeryville, CA-based Amyris could achieve impressive financial results simply by fulfilling its promises—even if that means hitting some fairly incremental goals. The company has seen its stock climb 72 percent, from $16 to … Continue reading “Amyris Sees Reward in Putting One Foot in Front of the Other in Biofuels”
MarketSharing Bets Small Businesses in New York and Beyond Will Clamor for Daily Deals
John Amato was working as president at New York ad agency Show Media when Groupon and other daily-deals sites started to take off a couple of years ago. Amato’s small agency rang up about $1 million a month in expenses, he says, which included buying iPods and other incentives for top-performing employees, and placing frequent … Continue reading “MarketSharing Bets Small Businesses in New York and Beyond Will Clamor for Daily Deals”
Carbonite Files for IPO, Autonomy Pays $380M for Iron Mountain Businesses, PerkinElmer Buys Labtronics, & More Boston-Area Deals News
We saw a mix of funding and acquisition news for New England’s tech and life sciences startups this week. —Carbonite, a Boston-based online data backup firm, revealed it was planning to go public. The company, which has raised more than $67 million in venture capital, didn’t yet say how many shares it will be offering … Continue reading “Carbonite Files for IPO, Autonomy Pays $380M for Iron Mountain Businesses, PerkinElmer Buys Labtronics, & More Boston-Area Deals News”
Healthcare Needs Real Entrepreneurs Before It Can Have Real Innovation
Earlier this week I had the pleasure of attending an event put together by the Agency for Healthcare Research and Quality, a branch of the US Department Of Health and Human Services whose mission is to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. AHRQ has established an Innovation Exchange … Continue reading “Healthcare Needs Real Entrepreneurs Before It Can Have Real Innovation”
From Kendall Square to Kenya: What’s Hot in Mobile
All my peers in tech seem to be talking about wireless these days. So this past Friday, I stepped outside my world of the data biz to attend the MassTLC tech event on “The Global Impact of Mobility” at the Kendall Square Marriott next to MIT. The event included panelists from industry (Groupon, BT, Cisco, … Continue reading “From Kendall Square to Kenya: What’s Hot in Mobile”
Hunting HiPPOs: Optimizely’s Testing Tools Bring Data-Driven Web Design to the Masses
Optimizely doesn’t put its most effective sales pitch on its website; it doesn’t have to. It boils down to this: If it was good enough for Barack Obama, it’s good enough for you. “It,” in this case, is online A/B testing: the practice of altering live websites in small, controlled ways to see whether the … Continue reading “Hunting HiPPOs: Optimizely’s Testing Tools Bring Data-Driven Web Design to the Masses”
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry
Merck isn’t messing around with its new hepatitis C drug. It has now enlisted a powerhouse partner in its bid to fight for market share against Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]). The Whitehouse Station, NJ-based pharma giant (NYSE: [[ticker:MRK]]) said today that it has formed a non-exclusive alliance with Roche’s Genentech unit to help … Continue reading “Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry”
German Wind Turbine Maker Kenersys To Establish Hemisphere Headquarters In Michigan
Kenersys, a German manufacturer of wind turbines, will base its North and South America operations in Michigan, a potential big boost for the state’s nascent cleantech industry. The company will spend $10.2 million to establish its headquarters in Troy, MI and build a manufacturing facility at a yet-to-be-determined site, according to the Michigan Economic Development … Continue reading “German Wind Turbine Maker Kenersys To Establish Hemisphere Headquarters In Michigan”
Microsoft’s Qi Lu Talks Future of the Web: Look Out, Facebook, Groupon, Apple, and (Oh Yeah) Google
If Microsoft has its way, you’ll soon be Skyping on your Windows Phone with 500 of your closest Facebook friends about the latest daily deals in your city. Then you’ll find those local businesses through Bing, which will help you decide which ones to pursue—and will help both merchants and consumers cash in on those … Continue reading “Microsoft’s Qi Lu Talks Future of the Web: Look Out, Facebook, Groupon, Apple, and (Oh Yeah) Google”
Red Hot: The Computer Science Job Market
It’s no secret that there’s extraordinary competition right now for computer scientists. Both nationally and regionally, new graduates from strong programs at all degree levels are receiving extraordinary offers. This year’s UW Computer Science & Engineering seniors have reported starting salaries as high as $105,000 (that’s the highest I’ve heard – there may be higher) … Continue reading “Red Hot: The Computer Science Job Market”
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A
Seattle-based Resolve Therapeutics raised its first $2 million to execute on a plan that challenges about 30 years of conventional wisdom of how you make money in biotech. And it took some creative thinking from a couple of New York-based venture firms to pull it together. The plan, crafted by Resolve CEO Jim Posada, is … Continue reading “Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A”
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments
Boston-based Foundation Medicine has only been around for about two years, but it’s already making friends in big places. Today the company—which is developing advanced cancer diagnostics—announced a collaboration with Celgene (NASDAQ: [[ticker:CELG]]), based in Summit, NJ. Celgene plans to use Foundation Medicine’s genomics testing technology in trials of cancer drugs, in the hopes of … Continue reading “Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments”